Valuation: Apeloa Pharmaceutical Co.,Ltd

Market Cap 26.36B 3.94B 3.5B 3.25B 2.95B 5.57B 374B 5.66B 39.02B 15.3B 195B 14.79B 14.47B 622B P/E 2026 *
24.5x
P/E 2027 * 21.5x
Enterprise Value 25.85B 3.86B 3.43B 3.18B 2.9B 5.46B 367B 5.55B 38.26B 15B 191B 14.5B 14.19B 610B EV / Sales 2026 *
2.5x
EV / Sales 2027 * 1.95x
Free-Float
45.08%
Yield 2026 *
1.32%
Yield 2027 * 1.43%
1 day-1.64%
1 week-7.80%
Current month-15.57%
1 month+1.43%
3 months+19.19%
6 months+31.72%
Current year+43.95%
1 week 23.09
Extreme 23.09
25.73
1 month 23.09
Extreme 23.09
28.5
Current year 15.19
Extreme 15.19
28.5
1 year 14.89
Extreme 14.89
28.5
3 years 10.66
Extreme 10.66
28.5
5 years 10.66
Extreme 10.66
41.87
10 years 4.86
Extreme 4.86
41.87
Manager TitleAgeSince
Chief Executive Officer 54 -
Director of Finance/CFO 54 -
President 52 -
Director TitleAgeSince
Director/Board Member 60 2005-04-14
Director/Board Member 61 2008-05-15
Chairman 54 2017-11-06
Date Insider Type Main position Quantity % Market Cap. Importance
4/26/23 Sell

Chief Executive Officer

6,200 0.0005%
6/28/22 Buy 50,000 0.0042%
6/28/22 Buy

Director

100,000 0.0085%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-7.80%+47.02%+21.98% 3.94B
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average -0.32%+2.73%+35.67%+57.32% 394.48B
Weighted average by Cap. +0.13%+3.82%+39.34%+71.77%

Financials

2026 *2027 *
Net sales 10.32B 1.54B 1.37B 1.27B 1.16B 2.18B 146B 2.22B 15.28B 5.99B 76.42B 5.79B 5.67B 244B 11.39B 1.7B 1.51B 1.4B 1.28B 2.41B 161B 2.45B 16.85B 6.61B 84.28B 6.39B 6.25B 269B
Net income 1.11B 165M 147M 136M 124M 234M 15.69B 238M 1.64B 642M 8.19B 620M 607M 26.1B 1.26B 189M 168M 156M 142M 267M 17.93B 272M 1.87B 734M 9.36B 709M 694M 29.83B
Net Debt -516M -77.15M -68.58M -63.56M -57.83M -109M -7.32B -111M -764M -300M -3.82B -290M -283M -12.18B -4.15B -620M -551M -511M -465M -877M -58.81B -891M -6.14B -2.41B -30.69B -2.33B -2.28B -97.84B
Projected Income Statement - Annual - Apeloa Pharmaceutical Co.,Ltd
Logo Apeloa Pharmaceutical Co.,Ltd
Apeloa Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Active Pharmaceutical Ingredient (API) intermediates, contract development and manufacturing organization (CDMO), preparations and others, as well as import and export trade. The Company operates three businesses. The API intermediates business mainly includes cephalosporin series, penicillin series, psychiatric series, cardiovascular and cerebrovascular series and veterinary API intermediates series. The CDMO business mainly includes research and development services, commercial human drug projects, commercial veterinary drug projects and other commercial products. The preparation business mainly includes anti-infective, cardiovascular and cerebrovascular, psychiatric and anti-tumor preparation products. The Company mainly operates its businesses in domestic and overseas markets.
Employees
6,787
Date Price Change Volume
26-10-16 CN¥23.42 -1.64% 15,091,098
26-10-15 CN¥23.81 -3.17% 14,066,760
26-10-14 CN¥24.59 -0.69% 10,261,279
26-10-13 CN¥24.76 +0.16% 13,707,924
26-10-12 CN¥24.72 -2.68% 18,684,186
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Apeloa Pharmaceutical Co.,Ltd
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
23.42CNY
Average target price
26.07CNY
Spread / Average Target
+11.30%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Apeloa Pharmaceutical Co.,Ltd
  1. Stock Market
  2. Stocks
  3. 000739 Stock